Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

170 Seattle * seroconvertors

12th World AIDS Conference

-Keyword

Abstract--

-Keyword

Abstract

ction among injectors in, USA/Drug treatment and HIV risk
e, and drug treatment in area drug injectors/The associatio
vior among users of the syringe exchange/Reduction in inj
-AIDS among first- and second-generation North African immigra
lymphoma (HIV-NHL)/ Second-line chemotherapy (CT) with CDE
he workplace/Private sector involvement in sustainable and inn
y in the AIDS voluntary in Rio de Janeiro, Brazil/Identities a
e NGOs and the public needs on HIV/AIDS prevention, Bra
HIV/AIDS on the health in Uganda/The impact of HIV/AIDS
y need from the health in Abidjan, C6te d'lvoire? An asses
epidemic on the health in C6te d'lvoire: Implementation of t
ence/Lawyers for legal involvement: The Nigerian Bar Ass
S: The non-government /Human rights and HIV/AIDS: The n
Statutory and voluntary involvement in the development of
ention in Siaya/Private integration in AIDS prevention in Si
nagement in the private in Osun State, Nigeria/STD manag
health program in rural /Absolute integration to sensitizatio
n six Brazilian informal mine areas/Knowledge, attitudes a
igations: Peasant food security in the context of AIDS in Malawi/ll
o HIV and AIDS/Social and law with regard to HIV and Al
re in Venezuela's social system void/Access to treatment/
d States/Assessing the of HIV/AIDS surveillance system
ity as a route to greater: The need for integrated outreach
h in US young gay men/ Self-acceptance of gay identity decreases
n health care settings/ Self-advocacy: Negotiating barriers relate
Title II Care Consortia/ Self-assessment modules: Evaluation an
one on AIDS: Tool for self-assessment and action by health dist
/AIDS/Development of self-care model for persons with HIV/AIDS
/Symptom distress and burden among women with late
/The social identity and self-concept of HIV-positive transgendere
nd cultural differences/ Self-disclosure of HIV serostatus to signifi
hic study of patterns of self-disclosure of HIV status to sexual par
nowledge, condom use self-efficacy and intention to practice safe
mme for adolescents on in AIDS prevention/An outre, using, an sharing your self-empowerment to empower others/Fi
ommunity support and self-esteem /Community AIDS program c
Personal and collective rescue and construction in Ri
DS/The importance of a self-governing organization in informing p
ers in Western Africa?/ Self-help groups of people with AIDS in C6
ng a drop-in-centre with self-help projects for people living with HIV
nched consumers on a programme founded by HIV+ ga
ment and propagation of groups of the HIV-infected/Cond
g groups/The role of the in mutual helping groups/The rol
s using audio computer self-interviewing among gay men and inj
d CD4 levels/Effects of self-management training on quality of life
rointestinal symptoms/ Self-prescribed marijuana use in patients
f HIV-infected adults/ Self-reported adherence to combination a
ial: Preliminary results/ adherence to ritonavir/saqui
ing study/Validation of self-reported sexual risk behavior with ST
orkers?/How valid are measures of drug use and c
HIV risk: Differences in strategies among Asian, Bla
e US/Better short term health outcomes for men wit
erostatus/Reliability of unprotected sex among part
actors associated with HIV disease among women
ble are sexual behavior self-reports? Instrument format and social
sk for HIV infection and of HIV antibody testing in a pr
py (HAART)/Transient self-resolving CMVviremia in responders
ctive workings plans for self-support groups of people living with H
g communities/From a group to an association's stru
ment guidelines in HIV: Self reported physician practices/Treatme
DS)/"Posit(HIV)e Life"/ -empowerment of people living with HI
iral (ARV) monitoring/ reported treatment adherence and dru
al STD prevention, and self reported STDs of first year university s
o live with HIV through help/Learning to live with HIV through
n life satisfaction and care ability in HIV infected persons/Eff
rapy as an approach to care/Wellness enhancement through
unity care/Encouraging shared confidentiality promotes self an
ions to guarantee their support and continued HIV/AIDS prev
n strategy and creating sustaining funding for HIV service prog
mbrella-organization for support-groups for HIV-positive peopl
ormity and exclusion in help organisations/Issues of conformit
x workers/Sex workers/ awareness among sex workers/Sex w
y? The role of patients' disclosure and trust in physicians/Ho
le of community based help groups in mobilsation and prevent

ussia/Positive Club - A help group of people with HIV in Russi
he shedding of HIV-1 in semen /Seminal cell-associated viral trans
1 viral load in blood and of subtype E infected Thai men/HI
d cell-associated HIV in /Influencing HIV infectivity: The eff
n/HIV quantification in: Evidence for a group at higher risk
subtype RNA levels in of HIV-1 infected Thai men does no

23223
33387
33400
60943
22297
13446
24102
43225
478*/43497
43515
43518
44153
44159
44276
60027
60260
60561
60877
24159
34329
42302
43430
60060
154*/14135
60743
44310
43536
22447
22462
60309
34198
44186
14265
33353
60153
34138
43214
34285
34283
24363
34252
34290
34298
43545
42371
60634
32338
32362
14107
14113
14219
14345
43428
60269
14102
43118
32241
34306
60982
24120
24273
32379
13500
14346
66*/22460
24314
33326
34128
34284
34286
34294
43315
60447
60940
60960

279*/11151
23390
23392
23394
23395

e condom: Exposure to during use/A prospective study of 33132
ains expressed using a Semliki forest virus vector/Antigenicity of 21207
c vaccine (ATV) using a sendai virus envelope derived adjuvant/St 60312
on of HIV-1 subtypes in Senegal by heteroduplex mobility assay ( 13112
erial vaginosis in Dakar ( )/Bacterial vaginosis in Dakar ( 13285
h on care and support in. Enda sante, Dakar, Senegal/A c 13431
DS program in prison in?/Which policy STD/AIDS progra 23511
a prisoners population, /Evidence for increasing of HIV inf 23575
h on care and support in: Enda Sante, Dakar, Senegal/A c 33312
e to the HIV epidemic in /Strengthening the community re 371*/34120
uccessfull case study in /HIV/AIDS control programm in Af 34161
m clinical specimens in /Comparison of mycobacteria gro 41169
n general population in: What do we know about HIV diffe 43441
d soldiers in the army in /STD/AIDS and soldiers in the ar 60841
V RNA in oral washes of Senegalese men and women/HIV RNA in 42135
rative study of two rural communities/AIDS, sexually 60138
Mycobacterium avium sensitin (MAS) in HIV+ persons with and 22171
s in Alexandria, Egypt/ Sentinel surveillance for HIV and high risk 13124
ex workers in Mexico: surveillance 1990-1997/Female 23547
Gomel region, Belarus/ surveillance conducted within the 43467
a from the National HIV Surveillance System/HIV in the P 521*/43508
TD patients 1992-1997/ surveillance in STD patients 1992 60492
s drug users in Mexico/ studies in intravenous drug users 60729
ex workers 1992-1997/ surveillance in female sex worker 60749
rs: Prevalence, clinical sequalae and treatment/Lipid abnormaliti 12319
ologous virus isolates/ Sera from early seroconvertors have high 31105
ralization by polyclonal sera /Study of the phenotype of primary HI 11211
rization of potent HIV-1 able to neutralize 17 primary HIV-1 is 31113
hemokine antibodies in of HIV-1-infected patients/Anti-chem 31161
dence rates/Pooling of for HIV viral RNA: Feasibility for diagn 42105
tibody-negative pooled /Detection of HIV-1 seroconvertors by 42107
r of viral RNA copies in of anergic patients with HIV disease/ 60721
mong rural population in Serbia /Sexual practice among rural popul 23429
rmed about AIDS?/Are Serbian secondary school pupils informed 13547
ory of the former USSR/ Sero- and genotyping of HIV-1 variants cir 13205
n different cities/HIV-1 sero- and genotyping of HIV/AIDS outbrea 13209
sociated with soldiers/ Sero-prevalence and risk behaviours amo 23471
abeth Hospital, Malawi/ of HIV-1 and other blood 33206
tion partner mixing and sero-prevalence and seroincidence: Post- 23206
ns in the use of sentinel sero-surveillance information for the eval 60668
ce from the HIV-ltalian seroconversion study/Effect of co-infecti 12108
thin 6 months after HIV,1987 to 1995/CD4+ res 12119
Epidemiology of HIV-1 among young adults in th 518*/13212
nzania/Risk factors for to syphilis: Results from a 13282
ith known dates of HIV /HHV-8 seropositivity an 13310
D4 counts following HIV in a male factory cohort/ 13316
al HIV-1 viral load after associated with HIV-1 dis 13322
IDS in the HIV-ltalian study (ISS)/Temporal ch 13323
/Survival following HIV evidence of a recent cha 189*/13335
ers/Symptomatic HIV-1 correlates with clinical, im 21116
maintenance trial/Low rate of HIV and of hepatiti 23211
ction behaviours in HIV among IV drug users in M 23221
miological analysis and rates/Work accidents:Ep 23334
M)/Risk factors for HIV in a contemporary cohort 23350
al load (VL) soon after (SC) has not increased b 23396
e forces/Risk for HIV-1 in the Ugandan people's 519*/23507
anti-HIV regimen/HBs of a precore hepatitis B vi 32118
everely ill patient/Slow of HIV in a severely ill pati 42138
atients 1995-1996/HIV rate in inner-city in-patien 43137
ete patient record from to clinical end points/The 43419
ween HIV infection and /A new combined HIV ant 60167
Study/Oral lesions and - The Tricontinental Stud 60301
UO, that narrows the "window"/Evaluation of a 60607
titis may foretell the HIV in heterosexuals/Tests f 60737
nsitions to injecting and seroconversions for HIV, hepatitis B and 13382
ter study/Very low HIV among injecting drug us 23169
ogression in 664 HIV-1 seroconverted injecting drug users in Eur 192*/13338
es in the Tricontinental Seroconverter Study/Risk factors for prog 13325
1 subtype E from recent seroconverters in Thailand/Genetic diver 13155
ion in 410 HIV infected /Combined effect of CCR 13183
S and death among HIV from Italy and Baltimore, 13332
o 1996 in 13,000 HIV-1 /Survival and progression 13337
gitudinal study of HIV-1 /Gender-specific differen 13379
otease coding region of /Genotypic prevalence of 41210
ubtype in recent military /The association of epide 60908

mmune reconstitution in seroconverting patients receiving triple a 12191
iretroviral-naive recent seroconvertors /Prevalence of HIV-1 resi 13215
olates/Sera from early have high neutralizing act 31105
HIV-1 positive German irrespective of viral subty 41208
era/Detection of HIV-1 by PCR in antibody-negat 42107